Evidence map›Paper›PMID 37594491›Full record

ArticleArchives of gynecology and obstetrics2024

Diabetes and pregnancy study (DAPSY): a 10-year single-center cohort study of pregnancies affected by diabetes.

Roman Kapustin, Ekaterina Kopteeva, Alena Tiselko, Elena Alekseenkova, Andrey Korenevsky, Elizaveta Shelaeva, Olga Arzhanova, Igor Kogan

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Roman KapustinD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Ekaterina KopteevaD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia. ekaterina_kopteeva@bk.ru.ORCID http://orcid.org/0000-0002-9328-8909
Alena TiselkoD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Elena AlekseenkovaD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Andrey KorenevskyD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Elizaveta ShelaevaD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Olga ArzhanovaD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Igor KoganD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductive Medicine, 3 Mendeleevskaya Line, St. Petersburg, 199034, Russia.
Research Institute of Obstetrics and Gynecology named after D.O. Ott · RU

Funding

Ministry of Science and Higher Education of the Russian Federation 1021062812133-0-3.2.2
6 · The paper itself

Abstract

purposeThe aim of our study was to investigate to what degree clinical characteristics can contribute to incidence and structure of pregnancy and childbirth complications in women with diabetes, and to reveal key risk factors for adverse outcomes.

methodsWe conducted a retrospective single-center cohort study from January 2008 through December 2017, including 3069 singleton pregnancies, affected by type 1 diabetes (T1D, n = 498), type 2 diabetes (T2D, n = 214), and gestational diabetes mellitus (GDM, n = 2357).

resultsMore than 10 years duration of T1D associated with increased risk for preterm birth (RR 2.03, 95% CI 1.28-3.20) and preeclampsia (RR 1.57, 95% CI 1.09-2.26). Diabetic nephropathy, same as diabetic proliferative retinopathy, was associated with increased risk of C-section, preeclampsia development, SGA delivery. In patients with T1D who received CSII (12%), we do not report superior outcomes compared to MDI. Pre-pregnancy HbA1c level less than 6.5% reduced the risk of preeclampsia for T1D (RR 0.28, 95% CI 0.19-0.67) and risk of LGA birth for T2D (RR 0.43, 95% CI 0.19-0.92). Achieving glycemic target values by full-term pregnancy reduced the risk of excessive fetal adiposity (RR 0.81 for T1D, RR 0.39 for T2D). For T2D and GDM, the leading risk factors were obesity and chronic hypertension. For patients with GDM, insulin administration and early diagnosis of GDM were the significant risk factors for adverse outcomes.

conclusionDiabetes during pregnancy is challenging for the clinician, but optimizing glycemic control, treatment regimens, and close attention to comorbidities can help to reduce the risks and ensure appropriate quality diabetes management.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Pre-EclampsiaPregnancy in DiabeticsPremature BirthAdultCesarean SectionCohort StudiesFemaleGlycated HemoglobinHumansInfant, NewbornPregnancyPregnancy OutcomeRetrospective StudiesGlycated HemoglobinCSIIGestational diabetes mellitusLGAMDIPreeclampsiaSGAType 1 diabetesType 2 diabetes

Identifiers

PMID37594491
OpenAlexW4385968416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.